North Carolina Marijuana News

Report co-author says results are preliminary but promising.

Researchers at the University of Saskatchewan say preliminary results suggest medicinal cannabis oil can reduce or completely stop seizures in children experiencing severe and drug-resistant epilepsy.

The study, funded by Jim Pattison’s Children’s Hospital Foundation, monitored seven children with severe pediatric epilepsy, a debilitating condition that can cause children to suffer as many as 1,200 seizures a month.

Dr. Richard Huntsman, a pediatric neurologist at the university’s college of medicine and one of the study’s authors, said the results are nascent but encouraging. The overall reduction in seizures was close to 75 per cent on average.

– Read the entire article at CBC News.

Read More Here…

It’s common these days to hear about a food or beverage company investing in cannabis. It’s more unusual for a cannabis company to, say, snap up a soda brand.

In recent months, an emerging cannabis firm has quickly acquired a significant position in Jones Soda (JSDA) with an eye on bringing the wild child of soft drinks into CBD beverages.

Late Thursday, Heavenly Rx, a hemp portfolio company of cannabis investment firm SOL Global Investments (SOLCF), invested $9 million to buy 15 million shares of Jones Soda, bringing its ownership stake in the Seattle soda company to 25%. The infusion is a welcome sum for Jones, which has been accumulating losses.

– Read the entire article at CNN News.

Read More Here…

Whether you’re a CBD newbie or you’ve been (literally) bathing in it for years, figuring out your ideal dose is incredibly confusing—until now.

CBD oil is unquestionably the most buzz-worthy ingredient right now. It’s so popular, in fact, that revenue from products made with CBD—the naturally-occurring compound present in the flowers and leaves of cannabis plants (there’s no THC, which means it can’t get you high)—are projected to grow to $20 billion by 2024.

Why? CBD is compelling to consumers largely because it comes with a laundry list of promising purported health benefits—from reduced anxiety to help with nausea, inflammation, and insomnia. We’re still waiting for clearance from the FDA (and more robust research on the the proven perks of the ingredient), but in the meantime, many consumers are eager to test out the positive potential of CBD.

– Read the entire article at Real Simple.

Read More Here…

Hundreds of academics across the country are waiting on a complex approval process to begin studying the impacts of cannabis on an array of topics including impacts on drivers, CTV News has learned.

Health Canada says that as it transitions hundreds of authorized research licences from the Narcotics Control Regulations to the Cannabis Act, “there have been challenges in processing times for new research licence applications.”

More than 350 existing research licensees are in the process, while only 65 new licences have been approved since cannabis was legalized Oct. 17, with another 250 applications at various stages of the review process.

– Read the entire article at News.

Read More Here…

CannTrust, which describes itself as a “leading” provider of medical cannabis, has voluntarily halted all sales and shipments of its product after Health Canada found that it was growing cannabis in five unlicensed rooms and after the ministry received inaccurate information.

The company has also set up a special committee to investigate the matter.

CannTrust is doing this as a “precaution” as Health Canada investigates the company’s facility in Vaughan, Ont., a company release said Thursday.

– Read the entire article at Global News.

Read More Here…

The U.S. government is growing the largest crop of marijuana for research purposes in five years, reports the Associated Press.

The increase is in response to the rapidly growing interest in marijuana strains with high levels of THC and CBD.

As noted by the AP, the government is the only source of cannabis for nearly all research in the U.S., while it still considers it illegal and dangerous. Mississippi, which holds the sole federal contract for producing marijuana. That’s enough for 5 million joints, although the government provides marijuana in different forms.

The crop will be divided between high THC and high CBD varieties with “recent interest (in CBD) as a potential medicine for a number of medical conditions,” NIDA said. The compound THC causes pot’s mind-altering effect; CBD doesn’t get people high.

Last year, a CBD-based drug was approved by federal regulators for two rare seizure disorders and researchers are pursuing research on it for other conditions. Others are focused on THC.

“We want to study what our patients are using,” said University of Colorado Assistant Professor Emily Lindley, who is investigating marijuana with high THC as an alternative to opioids for chronic back pain.

Lindley and

Read More Here…

A video of a drug bust released Thursday by the United States Coast Guard looks like a scene out of a Hollywood action movie

The footage shows members of the Coast Guard in pursuit of a semi-submarine—a vessel that was partially underwater, and partially exposed—that had been barreling through the eastern Pacific Ocean while carrying more than 17,000 pounds of cocaine.

“Stop your ship!” a member of the coast guard can be heard yelling in the minute-long footage, as his vessel bears down on the semi-submarine.

Midway through the video is when things get particularly dramatic. With the Coast Guard ship practically touching the target, a member of the crew eventually leaps atop the semi-submersible vessel, which is known as a “narco-sub.” As waves crash against him, the coast guardsman pounds on the top of the vessel before an individual, whose face was obscured by the Coast Guard, emerges from the submarine’s hatch.

The events documented in the video occurred on June 18. It was just one of 14 drug raids over the two months by the Coast Guard, as the U.S. ramps up its efforts to stop smugglers traversing from Central and South America. Since May, the Coast Guard

Read More Here…

Florida-based cannabis company Bhang went public on Thursday, with shares in the company beginning trading on the Canadian Stock Exchange. Shares in the company are listed under the ticker symbol BHNG and were up more than 70 percent in Friday morning trading.

Bhang currently owns a family of eight active brands with more than 100 cannabis and hemp products including cannabis edibles, beverages, oral sprays, pre-rolls, terpenes, and hemp-derived CBD consumer goods. The brand’s products are manufactured, sold, and distributed by the company directly and through licensing agreements with partners in jurisdictions with legal cannabis.

Bhang Expanding Its Reach

Bhang’s licensing arrangements include partnerships with Origin House/Crescp in California, Trulieve in Florida, and a 50/50 joint venture with Indiva for distribution in Canada and other international markets. The company’s plans for 2019 include launching eight new brands, offering more products, and expanding its availability to 2,000 stores from the current count of approximately 1,000.

Scott Van Rixel, the CEO of Bhang and a 2018 selectee for the High Times 100, said in a press release that going public will help fuel the company’s expansion goals.

“We’re proud to announce this major milestone for Bhang and the industry, as we see

Read More Here…

A Florida appellate court ruled on Tuesday that a law enacted to license cannabis providers in the state does not comply with the amendment that legalized medical marijuana and is therefore unconstitutional. The ruling by the 1st Court of Appeals in Tallahassee held that the law requiring cannabis businesses to be vertically integrated and handle all aspects of cannabis production from seed to sale created an oligopoly and should be struck down.

The court also upheld the lower court’s ruling that provisions of the medical marijuana regulations enacted by the state legislature that capped the number of licenses for providers also did not conform with the amendment passed by voters in 2016. The decision by a panel of three judges is expected to be further appealed to the Florida Supreme Court, according to media reports.

Suit Challenges Vertical Integration Requirements

A suit challenging the requirement that cannabis providers in the state be vertically integrated was filed by Florigrown, a company based in Tampa.
Leon Circuit Judge Charles Dodson, who heard the case, ruled in favor of the plaintiff, finding that the regulations passed by lawmakers in a 2017 legislative special session did not properly carry out the amendment. Dodson then issued

Read More Here…

Health insurance, paid holidays, half-price pot and the opportunity to spend every single day surrounded by top-shelf weed. Just a few of the perks and privileges that accompany a career as a budtender.

Unsurprisingly, the most appealing positions with leading dispensaries attract enormous attention. Even in smaller towns and cities across the U.S., you can expect heavy competition from other candidates. You’d be surprised how far some folks are willing to travel for a weed-related job they might actually enjoy.

As a result, it’s a good idea to ensure you’re well prepared. If you’re lucky enough to bag a budtender interview, you’ve passed the first test. But you still need to convince them you’re the right person for the job in a face-to-face interview.

During which, you can expect to be asked a whole bunch of weird and wonderful questions.

Of course, the exact questions you’ll be asked will differ from one establishment, interviewer, area and prospective position to the next. Nevertheless, you’ll almost certainly face most (or even all) of the following during your first budtender interview:

What are the main duties and responsibilities of budtenders?

Right off the bat, they’ll want to check whether you know what’s

Read More Here…